Research and Development Despite these challenges, the benefits of GLP-1 receptor agonistssuch as improved blood sugar control and weight managementare substantial, and research continues to focus on improving these therapies: Improving Formulations: Ongoing research aims to develop new formulations that might reduce side effects or offer easier methods of administration
When insurance formularies shift, patients who were stable on tirzepatide suddenly find themselves facing out-of-pocket costs exceeding $1,000 per month
PowellWiley, MD, MPH, Associate Editor, for review by expert referees, editorial decision, and final disposition
She has over 9 years of injections experience in both Australia and the U.S., and you can honestly tell
348,349 It is also noteworthy that CTE can lead to atypical astrocyte responses that contribute to recurrent seizures
TRIUMPH-4 enrolled 445 adults with obesity or overweight combined with knee osteoarthritis and tracked them for 68 weeks